CLINICAL_TRIALS
trial_result
· 2019-03-08
Clinical Trial Update: A Study of LY2605541 Versus Insulin Glargine on Blood Sugar [Phase 1]
Summary
Phase 1 trial comparing LY2605541 to insulin glargine in healthy volunteers and Type 1 diabetes patients has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Healthy Volunteers, Diabetes Mellitus, Type 1 | Phase 1 | Status: COMPLETED | Results posted: 2019-03-08